SJ-557733

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameSJ-557733
Drug Alias NameSJ-733SJ-557733(+)SJ-000557733
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsMalaria, VivaxMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaPeru
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaEisai Inc
Inactive CompaniesSt. Jude Children'S Research HospitalMedicines for Malaria Venture
Active IndicationsMalaria, VivaxMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A